Skip to main content

Table 1 Demographic and clinical profile of the enrolled cohort

From: Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217

Group

N

Sex (F%)

Age

Plasma Aβ40

Plasma Aβ42

Plasma Aβ42/40

Control

40

70

65.0 ± 6.7

299.2 ± 50.0

27.1 ± 5.01

0.088 ± 0.014

AD-dem

40

70

65.2 ± 9.4

291.7 ± 32.0

22.1 ± 2.50

0.076 ± 0.007

  1. Age defined as mean (years) ± SD. Plasma Aβ42 and Aβ40 levels defined as mean concentration (pg/mL) ± SD
  2. N number, F% female percentage, SD standard deviation
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193